Shenyang Xingqi Pharmaceutical Co Ltd (300573) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.145x

Based on the latest financial reports, Shenyang Xingqi Pharmaceutical Co Ltd (300573) has a cash flow conversion efficiency ratio of 0.145x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥268.97 Million ≈ $39.36 Million USD) by net assets (CN¥1.86 Billion ≈ $271.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shenyang Xingqi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Shenyang Xingqi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300573 total debt and obligations for a breakdown of total debt and financial obligations.

Shenyang Xingqi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenyang Xingqi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Trustmark Corporation NASDAQ:TRMK	0.027x
Ebos Group Ltd AU:EBO	0.011x
ADMA Biologics Inc NASDAQ:ADMA	0.075x
New Hope Dairy Co Ltd SHE:002946	0.113x
Netweb Technologies India Limited NSE:NETWEB	N/A
Philip Morris CR A.S. PR:TABAK	N/A
Daetwyl I SW:DAE	0.226x
ArcSoft Corp Ltd SHG:688088	0.041x

Annual Cash Flow Conversion Efficiency for Shenyang Xingqi Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Shenyang Xingqi Pharmaceutical Co Ltd (300573) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.59 Billion ≈ $233.13 Million	CN¥416.98 Million ≈ $61.02 Million	0.262x	+39.28%
2023-12-31	CN¥1.69 Billion ≈ $247.29 Million	CN¥317.57 Million ≈ $46.47 Million	0.188x	+1.90%
2022-12-31	CN¥1.55 Billion ≈ $227.15 Million	CN¥286.26 Million ≈ $41.89 Million	0.184x	-19.23%
2021-12-31	CN¥1.34 Billion ≈ $196.74 Million	CN¥306.96 Million ≈ $44.92 Million	0.228x	+29.72%
2020-12-31	CN¥694.06 Million ≈ $101.56 Million	CN¥122.16 Million ≈ $17.88 Million	0.176x	+36.59%
2019-12-31	CN¥574.90 Million ≈ $84.13 Million	CN¥74.08 Million ≈ $10.84 Million	0.129x	+62.38%
2018-12-31	CN¥554.58 Million ≈ $81.15 Million	CN¥44.01 Million ≈ $6.44 Million	0.079x	+34.31%
2017-12-31	CN¥553.38 Million ≈ $80.98 Million	CN¥32.70 Million ≈ $4.78 Million	0.059x	+9.45%
2016-12-31	CN¥520.95 Million ≈ $76.23 Million	CN¥28.12 Million ≈ $4.12 Million	0.054x	-1.82%
2015-12-31	CN¥389.79 Million ≈ $57.04 Million	CN¥21.43 Million ≈ $3.14 Million	0.055x	+55.59%
2014-12-31	CN¥367.81 Million ≈ $53.82 Million	CN¥13.00 Million ≈ $1.90 Million	0.035x	+41.72%
2013-12-31	CN¥336.80 Million ≈ $49.28 Million	CN¥8.40 Million ≈ $1.23 Million	0.025x	-82.72%
2012-12-31	CN¥290.70 Million ≈ $42.54 Million	CN¥41.96 Million ≈ $6.14 Million	0.144x	+45.29%
2011-12-31	CN¥247.00 Million ≈ $36.14 Million	CN¥24.54 Million ≈ $3.59 Million	0.099x	--

About Shenyang Xingqi Pharmaceutical Co Ltd

SHE:300573 China Medical Instruments & Supplies

Market Cap

$2.50 Billion

CN¥17.11 Billion CNY

Market Cap Rank

#5484 Global

#1113 in China

Share Price

CN¥69.45

Change (1 day)

-1.29%

52-Week Range

CN¥50.31 - CN¥83.32

All Time High

CN¥204.82